A
Active Biotech AB publ
STO:ACTI
Active Biotech AB publ
STO:ACTI
Price:
0.0606
SEK
-2.26%
Market Closed
Market Cap:
kr159.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Active Biotech AB publ
Cash Taxes Paid
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Active Biotech AB publ
Cash Taxes Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash Taxes Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Active Biotech AB publ
STO:ACTI
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Biogaia AB
STO:BIOG B
|
Cash Taxes Paid
kr112.9m
|
CAGR 3-Years
27%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Cash Taxes Paid
kr32.6m
|
CAGR 3-Years
127%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Cash Taxes Paid
kr202m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
18%
|
CAGR 10-Years
13%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Cash Taxes Paid
kr1.3B
|
CAGR 3-Years
25%
|
CAGR 5-Years
8%
|
CAGR 10-Years
51%
|
|
|
BioArctic AB
STO:BIOA B
|
Cash Taxes Paid
kr71.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Active Biotech AB publ
Glance View
Active Biotech AB engages in the development of pharmaceutical products. The company is headquartered in Lund, Skane. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
ACTI
Intrinsic Value
0.029
SEK
Overvaluation 52%
A
